Authors

• Angela C. Kothe (ORCID: https://orcid.org/0009-0000-7971-5292)
• John P. Berdahl (ORCID: https://orcid.org/0000-0002-5468-7405)
• Steven R. Sarkisian (ORCID: https://orcid.org/0000-0001-7633-2720)
• Inder Paul Singh
• Long V. Doan (ORCID: https://orcid.org/0009-0008-0572-2236)
• Lilit Voskanyan (ORCID: https://orcid.org/0000-0003-2829-9561)
• Robert Edward T. Ang (ORCID: https://orcid.org/0000-0002-5035-2923)
• Yan Shen (ORCID: https://orcid.org/0000-0002-7883-5169)
• David Applegate
• Tomas Navratil (ORCID: https://orcid.org/0009-0007-3577-3096)
• L. Jay Katz

Institutions

• Vance Thompson Vision (US)
• Northwest Eye Surgeons (US)
• Glaukos (United States) (US)
• Ophtalmological Center After S.V.Malayan (AM)
• Asian Eye Institute (PH)
• SC Johnson (United States) (US)

Publication Details

Journal

Drugs

Published

2024-09-06

DOI

https://doi.org/10.1007/s40265-024-02074-9

Citations

16

Primary Topic

Glaucoma and retinal disorders

Type

article

Field-Weighted Citation Impact

8.62

Funders

• Santen
• Allergan